TileDB

Founded by Flagship Pioneering, Cellarity operates at the intersection of biology, chemistry, high-dimensional data, and machine learning, developing game-changing medicines unreachable with traditional drug discovery methods. The Cellarity team needs to manage hundreds of millions of cells spread across datasets with a file-based storage approach. Yet, the approach's limits in scale and functionality resulted in inefficient data wrangling among their engineers and scientists. With TileDB, the team fulfills all their requirements for analysis-ready single-cell data on cloud storage while massively reducing their data engineering burden. In their own words: "𝘛𝘪𝘭𝘦𝘋𝘉 𝘩𝘢𝘴 𝘪𝘮𝘱𝘳𝘰𝘷𝘦𝘥 𝘰𝘶𝘳 𝘤𝘰𝘮𝘱𝘶𝘵𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘱𝘦𝘳𝘧𝘰𝘳𝘮𝘢𝘯𝘤𝘦 𝘢𝘯𝘥 𝘰𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘤𝘺. 𝘉𝘺 𝘳𝘦𝘥𝘶𝘤𝘪𝘯𝘨 𝘵𝘩𝘦 𝘥𝘢𝘵𝘢 𝘦𝘯𝘨𝘪𝘯𝘦𝘦𝘳𝘪𝘯𝘨 𝘣𝘶𝘳𝘥𝘦𝘯, 𝘰𝘶𝘳 𝘔𝘓 𝘢𝘯𝘥 𝘤𝘰𝘮𝘱𝘶𝘵𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘴𝘤𝘪𝘦𝘯𝘵𝘪𝘴𝘵𝘴 𝘤𝘢𝘯 𝘧𝘰𝘤𝘶𝘴 𝘰𝘯 𝘵𝘩𝘦 𝘴𝘤𝘪𝘦𝘯𝘤𝘦." Read more 👇 https://hubs.la/Q02ZxBly0

⌛1 day left until our next webinar! Integrating #multimodal data - such as health records, #multiomics data, or clinical images - to mine insights is challenging due to the complexity and scale involved. A top 20 #pharma solved this challenge using TileDB and Zifo. Join Chad Nicholas K., Senior Genomics Solution Architect at TileDB, and Ragavi Shanmugam from Zifo for TileDB's next technical webinar on November 21st, where we'll dive into integrating multimodal data, making it FAIR-ready (Findable, Accessible, Interoperable, and Reusable), and much more. Registration link in the comments. Chad, our presenter, explains more 👇

As #lifesciences organizations strive to unlock the full potential of their data, integrating diverse modalities like clinical data, multiomics, and medical images poses significant challenges. These #multimodal datasets hold immense value, but aligning data standards, ensuring interoperability, and scaling the required computational resources can be daunting. Regulatory compliance and data privacy concerns add further complexity, while siloed data sources and a lack of cross-functional collaboration create a chicken-and-egg problem. What do you see as the biggest hurdle your organization faces? Share your perspective in the poll below 👇 P.S. In our upcoming webinar, we'll explore how a top 20 pharma company tackled the complexities of integrating multimodal data. (link in comments)

🎉 We are proud to announce that TileDB is now utilized by 50% of the top 20 global pharmaceutical companies, including industry leader Boehringer Ingelheim. This adoption underscores TileDB's foundational role in advancing precision medicine through drug discovery pipelines that are increasingly powered by research on #multimodal, #multiomics data. Read more https://hubs.la/Q02Yl3kD0

We are thrilled to announce major expansions at TileDB, including strategic appointments to our board and leadership team and the opening of our NYC office. New board appointments: ⚬ George Llado - Former SVP & CIO of Alexion Pharmaceuticals, Inc., joining as Independent Director ⚬ Jeff Miller - Operating Partner at Two Bear Capital, joining as Board Observer Senior Leadership appointments, collectively representing decades of experience in the database and SaaS markets: ⚬ Eric Goldstein - Chief Revenue Officer ⚬ Julie Bryce - Chief Marketing Officer ⚬ Tom Hannon - Head of Finance ⚬ Paolo Narvaez - VP of Product With these new appointments, we are expanding our leadership capabilities to enhance our market reach and strengthen our go-to-market capability, solidifying TileDB's status as the preferred foundation for scientific breakthroughs.

Struggling with combining #multimodal data to generate insights? A top 20 #pharma solved this challenge using TileDB and Zifo. Curious how they did it? We'll break it down in our upcoming webinar on November 21st. Chad, our presenter, explains it all 👇

Multimodal data - such as health records, multiomics data, or clinical images enables decision-making throughout the drug discovery and development process. However, integrating multimodal data to mine insights is challenging due to the complexity and scale involved. So, how can practitioners in biopharma overcome this challenge? Join our upcoming webinar to find out! 📅 November 21 | 1:00 PM EST Chad Nicholas K., Senior Genomics Solution Architect at TileDB, and Ragavi Shanmugam, Senior Bioinformatician at Zifo, will present how a top 20 pharma organization leveraged TileDB and Zifo to integrate clinical metadata, genomic data, and public annotations into a tool usable by scientists to identify disease mechanisms and therapeutic targets. What you'll learn: 💡 Unlocking biological insights with multimodal data 💡 Driving insights through FAIR data integration 💡 Future-proofing for multi-omics using TileDB Register https://lnkd.in/gfx6kEcP

Product update - you can now run spatial transcriptomics on TileDB. Our latest product release (in development preview) offers support for spatial datasets, enabling scientists and data teams at pharma, biotech, universities, and academic medical centers to catalog large datasets of #spatial data on cloud cost-effectively while maximizing flexibility and interoperability with existing analytical toolkits. Combine the precision of #singlecell data with the context of imaging data. 👉 Sign up for a development preview: https://hubs.la/Q02XlbM_0 📖 Learn more: https://hubs.la/Q02Xly4L0

Together with our partner Amazon Web Services (AWS), we’re sponsoring a meetup during #ASHG24 in Denver on November 7. Join Jeremy Balian, Chase C., and our partners for a night of food, fun, and networking! Limited seats available - RSVP below to secure your spot 👇 https://lnkd.in/greT2hZR

Is your team's infrastructure 2025-proof? Tomorrow's webinar sheds light on this challenge! Seth Shelnutt will explain how to choose the right #multimodal data platform to support your #drugdiscovery goals for 2025 and beyond. See you there! 👇 https://lnkd.in/eCpuuMd6